These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16237777)
1. Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients. Zhao P; Liu W; Lu YL World J Gastroenterol; 2005 Sep; 11(36):5735-8. PubMed ID: 16237777 [TBL] [Abstract][Full Text] [Related]
2. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings. Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387 [TBL] [Abstract][Full Text] [Related]
3. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition. Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters. Skopelitou AS; Mitselou A; Katsanos KH; Alexopoulou V; Tsianos EV Eur J Gastroenterol Hepatol; 2003 May; 15(5):515-23. PubMed ID: 12702909 [TBL] [Abstract][Full Text] [Related]
5. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma. Zhao P; Lu Y; Zhong M; Liu L; Li B Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300 [TBL] [Abstract][Full Text] [Related]
6. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival. Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas. Segawa T; Sasagawa T; Saijoh K; Inoue M Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085 [TBL] [Abstract][Full Text] [Related]
8. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980 [TBL] [Abstract][Full Text] [Related]
9. FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study. Mady HH; Melhem MF Clin Exp Metastasis; 2002; 19(4):351-8. PubMed ID: 12090476 [TBL] [Abstract][Full Text] [Related]
10. Loss of fragile histidine triad expression in colorectal carcinoma. Zhao P; Lu Y; Hu Y; Zhong M; Li Z; Li X Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):124-7. PubMed ID: 12419158 [TBL] [Abstract][Full Text] [Related]
11. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions. Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892 [TBL] [Abstract][Full Text] [Related]
12. Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia. Hayashi A; Yashima K; Takeda Y; Sasaki S; Kawaguchi K; Harada K; Murawaki Y; Ito H J Gastroenterol Hepatol; 2012 Nov; 27(11):1752-8. PubMed ID: 22742976 [TBL] [Abstract][Full Text] [Related]
13. The significance of fragile histidine triad protein as a molecular prognostic marker of bladder urothelial carcinoma. Zhang CT; Lu R; Lin YL; Liu RL; Zhang ZH; Yang K; Dang RF; Zhang HT; Shen YG; Kong PZ; Ren HL; Li XL; Quan W; Xu Y J Int Med Res; 2012; 40(2):507-16. PubMed ID: 22613411 [TBL] [Abstract][Full Text] [Related]
14. Fhit protein expression in human gastric cancer and related precancerous lesions. Caselli M; Marchisio M; Gaudio M; Saragoni L; Lanza G; Alvisi V; Bertagnolo V; Concu M; Capitani S; Caramelli E Oncol Rep; 2001; 8(6):1233-7. PubMed ID: 11605039 [TBL] [Abstract][Full Text] [Related]
15. [Expressions of cyclinB1, FHIT and Ki-67 in 336 gastric carcinoma patients and their clinicopathologic significance]. Li YZ; Zhao P Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(33):2337-41. PubMed ID: 20095356 [TBL] [Abstract][Full Text] [Related]
16. [Fragile histidine triad protein expression and correlation with apoptosis in rectal carcinoma]. Cao J; Xia J; Wang H; DU H; Li WL Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):177-81. PubMed ID: 17380463 [TBL] [Abstract][Full Text] [Related]
17. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer. Rocco A; Schandl L; Chen J; Wang H; Tulassay Z; McNamara D; Malfertheiner P; Ebert MP J Cancer Res Clin Oncol; 2003 Feb; 129(2):84-8. PubMed ID: 12669232 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma. Xiao YP; Wu DY; Xu L; Xin Y World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697 [TBL] [Abstract][Full Text] [Related]
19. Loss of fragile histidine triad protein in human hepatocellular carcinoma. Zhao P; Song X; Nin YY; Lu YL; Li XH World J Gastroenterol; 2003 Jun; 9(6):1216-9. PubMed ID: 12800227 [TBL] [Abstract][Full Text] [Related]
20. [Loss of fragile histidine triad expression and metastasis in breast cancer]. Zhao P; Li XY; Chen LZ Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]